FDA issues first approval for remote continuous-glucose-monitoring app

Modern Healthcare (complimentary online subscription): The Food and Drug Administration has approved the first mobile medical app that will allow remote monitoring of patient glucose data.The technology, from medical device firm Dexcom, had been “eagerly awaited by the diabetes community, especially caregivers of children with diabetes who want to monitor their glucose levels remotely,” said Alberto Gutierrez, the FDA's director of the office of in vitro diagnostics and radiological health.

Read article